115 related articles for article (PubMed ID: 2559379)
21. [Scintigraphic observation of cancer with 99mTc(V)-DMS].
Ohta J; Endo K; Kotoura Y; Torizuka K
Rinsho Hoshasen; 1984 Aug; 29(8):935-6. PubMed ID: 6096599
[No Abstract] [Full Text] [Related]
22. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
[TBL] [Abstract][Full Text] [Related]
23. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus C; Mistry R; Maisey MN
Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
[TBL] [Abstract][Full Text] [Related]
24. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases.
Lam AS; Kettle AG; O'Doherty MJ; Coakley AJ; Barrington SF; Blower PJ
Nucl Med Commun; 1997 Oct; 18(10):907-14. PubMed ID: 9392790
[TBL] [Abstract][Full Text] [Related]
25. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Eur J Nucl Med; 1992; 19(10):890-3. PubMed ID: 1333404
[TBL] [Abstract][Full Text] [Related]
26. 99mTechnetium(V) dimercaptosuccinic acid (99mTc(v) DMSA) as a tumour seeking agent in nasopharyngeal carcinoma.
Aw SE; Sundram FX; Goh AS
Ann Acad Med Singap; 1986 Oct; 15(4):498-501. PubMed ID: 3032068
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m (V) DMSA uptake in amyloidosis.
Ohta H; Endo K; Kanoh T; Konishi J; Kotoura H
J Nucl Med; 1989 Dec; 30(12):2049-52. PubMed ID: 2555464
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a DMSA kit for instant preparation of 99mTc(V)-DMSA for tumour and metastasis scintigraphy.
Chauhan UP; Babbar A; Kashyap R; Prakash R
Int J Rad Appl Instrum B; 1992 Nov; 19(8):825-30. PubMed ID: 1330991
[TBL] [Abstract][Full Text] [Related]
29. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
[TBL] [Abstract][Full Text] [Related]
30. Replacing 99Tcm-DMSA for renal imaging?
Piepsz A; Pintelon H; Verboven M; Keuppens F; Jacobs A
Nucl Med Commun; 1992 Jul; 13(7):494-6. PubMed ID: 1323086
[TBL] [Abstract][Full Text] [Related]
31. The pharmacokinetics and biodistribution of technetium-99m(V)dimercaptosuccinic acid in an animal tumor model.
Watkinson JC; Allen SJ; Laws DE; Lazarus CR; Maisey MN; Clarke SE
J Nucl Med; 1991 Jun; 32(6):1235-8. PubMed ID: 1646304
[TBL] [Abstract][Full Text] [Related]
32. 99Tcm-DMSA uptake in obstructed kidneys. How inaccurate are the 5 h measurements?
Verboven M; Ham HR; Josephson S; Collier F; Hall M; Piepsz A
Nucl Med Commun; 1987 Jan; 8(1):45-8. PubMed ID: 3033571
[TBL] [Abstract][Full Text] [Related]
33. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
34. Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA.
Hirano T; Otake H; Yoshida I; Endo K
J Nucl Med; 1995 Feb; 36(2):202-7. PubMed ID: 7830114
[TBL] [Abstract][Full Text] [Related]
35. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
[TBL] [Abstract][Full Text] [Related]
37. Medullary carcinoma of the thyroid: management of persistent hypercalcitonaemia utilizing [99mTc] (v) dimercaptosuccinic acid scintigraphy.
Udelsman R; Mojiminiyi OA; Soper ND; Buley ID; Shepstone BJ; Dudley NE
Br J Surg; 1989 Dec; 76(12):1278-81. PubMed ID: 2557953
[TBL] [Abstract][Full Text] [Related]
38. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
[TBL] [Abstract][Full Text] [Related]
39. Comparison of 99Tcm dimercaptosuccinic acid scans and intravenous urography in children.
Whitear P; Shaw P; Gordon I
Br J Radiol; 1990 Jun; 63(750):438-43. PubMed ID: 2165841
[TBL] [Abstract][Full Text] [Related]
40. 99Tcm-DMSA as a dynamic imaging agent for estimating renal blood flow. A comparison with 99Tcm-DTPA.
Bunce CJ; Godley ML; Snell ME
Nucl Med Commun; 1994 Jul; 15(7):511-4. PubMed ID: 7970427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
